New aspects of the epigenetic regulation of EMT related to pulmonary fibrosis

Eur J Pharmacol. 2023 Oct 5:956:175959. doi: 10.1016/j.ejphar.2023.175959. Epub 2023 Aug 2.

Abstract

Pulmonary fibrosis is a chronic and progressive fibrotic disease that results in impaired gas exchange, ventilation, and eventual death. The pro-fibrotic environment is instigated by various factors, leading to the transformation of epithelial cells into myofibroblasts and/or fibroblasts that trigger fibrosis. Epithelial mesenchymal transition (EMT) is a biological process that plays a critical role in the pathogenesis of pulmonary fibrosis. Epigenetic regulation of tissue-stromal crosstalk involving DNA methylation, histone modifications, non-coding RNA, and chromatin remodeling plays a key role in the control of EMT. The review investigates the epigenetic regulation of EMT and its significance in pulmonary fibrosis.

Keywords: Epigenetics; Epithelial mesenchymal transition; Pulmonary fibrosis.

Publication types

  • Review

MeSH terms

  • Epigenesis, Genetic
  • Epithelial-Mesenchymal Transition / genetics
  • Fibrosis
  • Humans
  • Lung / pathology
  • Pulmonary Fibrosis* / genetics
  • Pulmonary Fibrosis* / pathology